Dr. Aaron Gerds, MD, MS
Claim this profileCleveland Clinic Foundation
Studies Myelofibrosis
Studies Primary Myelofibrosis
11 reported clinical trials
17 drugs studied
Area of expertise
1Myelofibrosis
ANC
platelets
AST
2Primary Myelofibrosis
Affiliated Hospitals
Clinical Trials Aaron Gerds, MD, MS is currently running
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Selinexor
for Myelofibrosis
The main purpose of this study with corresponding optional expansion is to evaluate the efficacy of selinexor in JAKi-naïve participants with myelofibrosis (MF) and moderate thrombocytopenia based on spleen volume reduction (SVR). Additional efficacy and safety parameters will also be assessed during the study.
Recruiting1 award Phase 28 criteria
More about Aaron Gerds, MD, MS
Clinical Trial Related6 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Aaron Gerds, MD, MS has experience with
- Placebo
- Luspatercept
- 9-ING-41
- Ruxolitinib
- DISC-0974
- Pelabresib (CPI-0610)
Breakdown of trials Aaron Gerds, MD, MS has run
Primary Myelofibrosis
Myeloproliferative Disorder
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Aaron Gerds, MD, MS specialize in?
Aaron Gerds, MD, MS focuses on Myelofibrosis and Primary Myelofibrosis. In particular, much of their work with Myelofibrosis has involved ANC patients, or patients who are platelets.
Is Aaron Gerds, MD, MS currently recruiting for clinical trials?
Yes, Aaron Gerds, MD, MS is currently recruiting for 3 clinical trials in Cleveland Ohio. If you're interested in participating, you should apply.
Are there any treatments that Aaron Gerds, MD, MS has studied deeply?
Yes, Aaron Gerds, MD, MS has studied treatments such as Placebo, Luspatercept, 9-ING-41.
What is the best way to schedule an appointment with Aaron Gerds, MD, MS?
Apply for one of the trials that Aaron Gerds, MD, MS is conducting.
What is the office address of Aaron Gerds, MD, MS?
The office of Aaron Gerds, MD, MS is located at: Cleveland Clinic Foundation, Cleveland, Ohio 44195 United States. This is the address for their practice at the Cleveland Clinic Foundation.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.